Benzinga | Nov 15, 2021 05:47PM EST

Cyclo Therapeutics Q3 EPS $(0.60), Sales $403.90K

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.60) per share. The company reported $403.90 thousand in sales this quarter.